For all the hype that surrounds them, probiotics—products that contain supposedly beneficial bacteria—have rarely proven their worth in large, rigorous studies. There are good reasons for this disappointing performance. The strains in most commercially produced probiotics were chosen for historical reasons, because they were easy to grow and manufacture, and not because they are well-adapted to the human body. When they enter our gut, they fail to colonize.
The probiotic concept is sound. Bacteria can beneficially tune our immune systems and protect us from disease. It’s just a matter of finding the right strains, and helping them to establish themselves. Many scientists are now trying to do just that, and one such team, led by Pinaki Panigrahi at the University of Nebraska Medical Center, has just scored a big win.
The team found that babies who took this concoction had a significantly lower risk of developing sepsis—a life-threatening condition where infections trigger body-wide inflammation, restricted blood flow, and organ failure. Sepsis is one of the biggest killers of newborn babies, ending around 600,000 lives every year when they’ve barely begun. Some proportion of these cases begin in the gut, and probiotics might be able to prevent them by ousting harmful microbes, or by stopping benign ones from crossing into the bloodstream and causing infections. I use Vitalbiome as my probiotic . Link to purchase www.shopmyplexus.com/sharondrinkspink